UBCP vs. NVO
UBCP (United Bancorp, Inc.) and NVO (Novo Nordisk A/S) are both stocks. UBCP operates in Banks - Regional (Financial Services), while NVO operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, UBCP returned 10.73%/yr vs 8.17%/yr for NVO. At a 0.00 correlation, their price movements are largely independent.
Performance
UBCP vs. NVO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, UBCP achieves a 17.43% return, which is significantly higher than NVO's -1.67% return. Over the past 10 years, UBCP has outperformed NVO with an annualized return of 10.73%, while NVO has yielded a comparatively lower 8.17% annualized return.
UBCP
- 1D
- -0.55%
- 1M
- 6.79%
- YTD
- 17.43%
- 6M
- 15.30%
- 1Y
- 19.31%
- 3Y*
- 18.38%
- 5Y*
- 9.03%
- 10Y*
- 10.73%
NVO
- 1D
- 0.56%
- 1M
- 6.06%
- YTD
- -1.67%
- 6M
- -2.80%
- 1Y
- -26.15%
- 3Y*
- -13.58%
- 5Y*
- 5.11%
- 10Y*
- 8.17%
UBCP vs. NVO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
UBCP United Bancorp, Inc. | 17.43% | 17.96% | 8.37% | -6.95% | -7.37% | 32.06% | -3.73% | 31.06% | -10.12% | 1.89% |
NVO Novo Nordisk A/S | -1.67% | -39.22% | -15.93% | 54.84% | 22.66% | 63.52% | 23.33% | 28.70% | -12.98% | 52.92% |
Correlation
The correlation between UBCP and NVO is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.09 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.03 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.01 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.01 |
Correlation (All Time) Calculated using the full available price history since Aug 18, 1995 | 0.00 |
Fundamentals
UBCP:
$89.39M
NVO:
$215.05B
UBCP:
$1.39
NVO:
DKK 27.42
UBCP:
11.68
NVO:
11.57
UBCP:
1.90
NVO:
4.30
UBCP:
1.34
NVO:
6.95
UBCP:
$47.82M
NVO:
DKK 327.80B
UBCP:
$32.28M
NVO:
DKK 268.30B
UBCP:
$8.59M
NVO:
DKK 181.54B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
UBCP vs. NVO — Risk / Return Rank
UBCP
NVO
UBCP vs. NVO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for United Bancorp, Inc. (UBCP) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| UBCP | NVO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.10 | ||
| Sortino ratioReturn per unit of downside risk | +1.43 | ||
| Omega ratioGain probability vs. loss probability | 1.13 | 0.94 | +0.19 |
| Calmar ratioReturn relative to maximum drawdown | 1.20 | -0.53 | +1.73 |
| Martin ratioReturn relative to average drawdown | 2.73 | -0.84 | +3.57 |
Loading charts...
Drawdowns
UBCP vs. NVO - Drawdown Comparison
The maximum UBCP drawdown since its inception was -67.81%, smaller than the maximum NVO drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for UBCP and NVO.
Loading charts...
Drawdown Indicators
| UBCP | NVO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -67.81% | -74.70% | +6.89% |
Max Drawdown (1Y)Largest decline over 1 year | -16.23% | -49.17% | +32.94% |
Max Drawdown (3Y)Largest decline over 3 years | -24.14% | -74.70% | +50.56% |
Max Drawdown (5Y)Largest decline over 5 years | -48.00% | -74.70% | +26.70% |
Max Drawdown (10Y)Largest decline over 10 years | -48.00% | -74.70% | +26.70% |
Current DrawdownCurrent decline from peak | -3.25% | -64.87% | +61.62% |
Average DrawdownAverage peak-to-trough decline | -23.28% | -17.83% | -5.45% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.08% | 31.10% | -24.02% |
Volatility
UBCP vs. NVO - Volatility Comparison
The current volatility for United Bancorp, Inc. (UBCP) is 9.29%, while Novo Nordisk A/S (NVO) has a volatility of 11.68%. This indicates that UBCP experiences smaller price fluctuations and is considered to be less risky than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| UBCP | NVO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.29% | 11.68% | -2.39% |
Volatility (6M)Calculated over the trailing 6-month period | 26.43% | 37.71% | -11.28% |
Volatility (1Y)Calculated over the trailing 1-year period | 33.00% | 51.65% | -18.65% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 36.74% | 38.48% | -1.74% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 35.32% | 32.57% | +2.75% |
Dividends
UBCP vs. NVO - Dividend Comparison
UBCP's dividend yield for the trailing twelve months is around 5.78%, more than NVO's 3.73% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NVO Novo Nordisk A/S | 3.73% | 3.31% | 1.68% | 1.00% | 1.20% | 1.35% | 1.87% | 2.14% | 1.45% | 1.52% | 2.87% | 0.92% |
UBCP United Bancorp, Inc. | 5.78% | 6.41% | 6.58% | 6.35% | 5.26% | 4.11% | 4.32% | 3.81% | 4.55% | 3.47% | 3.48% | 4.38% |
Financials
UBCP vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between United Bancorp, Inc. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
UBCP vs. NVO - Profitability Comparison
UBCP - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, United Bancorp, Inc. reported a gross profit of 7.91M and revenue of 11.44M. Therefore, the gross margin over that period was 69.1%.
NVO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a gross profit of 83.23B and revenue of 96.82B. Therefore, the gross margin over that period was 86.0%.
UBCP - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, United Bancorp, Inc. reported an operating income of 1.75M and revenue of 11.44M, resulting in an operating margin of 15.3%.
NVO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported an operating income of 59.62B and revenue of 96.82B, resulting in an operating margin of 61.6%.
UBCP - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, United Bancorp, Inc. reported a net income of 1.91M and revenue of 11.44M, resulting in a net margin of 16.7%.
NVO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a net income of 48.56B and revenue of 96.82B, resulting in a net margin of 50.2%.
Frequently Asked Questions
UBCP and NVO have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NVO has higher volatility (11.68%) compared to UBCP (9.29%). In terms of maximum drawdown, UBCP dropped -67.81% vs NVO's -74.70%.
UBCP currently has the higher Sharpe Ratio (0.59 vs -0.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for UBCP and NVO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer